Cangrelor is a RESTRICTED formulary medication. Use of Cangrelor is restricted to: - patients who are on oral antiplatelet and have a scheduled procedure in the next 4 days necessitating holding of the oral medication. - patients needing antiplatelet therapy who are NPO for all medications. - patients needing antiplatelet therapy who are not achieving adequate function with clopidigrel, as indicated by Platelet Reaction Units (PRU) greater than 180 using the “VerifyNow P2Y12 monitoring system”.
All other use of Cangrelor requires approval by Pharmacy Leadership.
Add Formweb to your mobile device
Cangrelor is a RESTRICTED formulary medication. Use of Cangrelor is restricted to:
- patients who are on oral antiplatelet and have a scheduled procedure in the next 4 days necessitating holding of the oral medication.
- patients needing antiplatelet therapy who are NPO for all medications.
- patients needing antiplatelet therapy who are not achieving adequate function with clopidigrel, as indicated by Platelet Reaction Units (PRU) greater than 180 using the “VerifyNow P2Y12 monitoring system”.
All other use of Cangrelor requires approval by Pharmacy Leadership.